Page last updated: 2024-10-17

aminocaproic acid and Urethral Neoplasms

aminocaproic acid has been researched along with Urethral Neoplasms in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Urethral Neoplasms: Cancer or tumors of the URETHRA. Benign epithelial tumors of the urethra usually consist of squamous and transitional cells. Primary urethral carcinomas are rare and typically of squamous cells. Urethral carcinoma is the only urological malignancy that is more common in females than in males.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taylor, RN1
Lacey, CG1
Shuman, MA1

Other Studies

1 other study available for aminocaproic acid and Urethral Neoplasms

ArticleYear
Adenocarcinoma of Skene's duct associated with a systemic coagulopathy.
    Gynecologic oncology, 1985, Volume: 22, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Aminocaproic Acid; Blood Transfusion; Disseminated Intravascular Coagul

1985